Does a Patient-managed (PAT) Insulin Intensification Strategy with Insulin Glargine (iGla) and Insulin Glulisine (iGlu) Provide Similar Glycemic Control as Healthcare Professional-managed (HCP) Strategy? Results of the START Study Journal Articles